Netilmicin in Gram-Negative Bacterial Infections

Netilmicin, a new semisynthetic aminoglycoside, was used in the treatment of 42 patients with serious gram-negative bacterial infections. Of the 40 evaluable patients, 24 (60%) were cured, and 8 (20%) had a favorable clinical response, for a total clinical response rate of 80%. Eight patients failed...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Snydman, David R., Tally, Francis P., Landesman, Sheldon H., Barza, Michael, Gorbach, Sherwood L.
Format: Artigo
Jezik:Inglês
Izdano: 1979
Teme:
Pharmacology and Therapeutics
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC352599/
https://ncbi.nlm.nih.gov/pubmed/426506
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki